<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[3, 6] sputum inflammatory indices<br>[159, 169] sputum leukocyte density and IL-1beta, IL-8, and LTB4<br>[185, 187] exacerbation.<br>[193, 194] spirometry<br>[202, 204] adverse reactions<br>[224, 230] sputum inflammatory indices in bronchiectasis.<br>[253, 255] bronchiectasis.<br></td>
<td width=33%>
[3, 6] sputum inflammatory indices<br>[19, 21] bronchiectasis,<br>[30, 37] inflammatory and infective markers in bronchiectasis.<br>[62, 64] bronchiectasis.<br>[108, 119] 24-h sputum volume, sputum leukocyte density, bacterial densities,<br>[120, 139] concentrations of interleukin (IL)-1beta, IL-8, tumor necrosis factor-alpha (TNF-alpha),<br>[140, 142] leukotriene B4<br>[159, 169] sputum leukocyte density and IL-1beta, IL-8, and LTB4<br>[185, 187] exacerbation.<br>[193, 194] spirometry<br>[202, 204] adverse reactions<br>[224, 230] sputum inflammatory indices in bronchiectasis.<br>[250, 255] inflammatory components in bronchiectasis.<br></td>
<td width=33%>
[2, 6] reduces sputum inflammatory indices<br>[19, 21] bronchiectasis,<br>[30, 37] inflammatory and infective markers in bronchiectasis.<br>[61, 64] in bronchiectasis.<br>[106, 145] spirometry, 24-h sputum volume, sputum leukocyte density, bacterial densities, and concentrations of interleukin (IL)-1beta, IL-8, tumor necrosis factor-alpha (TNF-alpha), and leukotriene B4 (LTB4)<br>[159, 169] sputum leukocyte density and IL-1beta, IL-8, and LTB4<br>[183, 187] episodes of exacerbation.<br>[193, 194] spirometry<br>[201, 204] reported adverse reactions<br>[220, 230] effective in reducing the sputum inflammatory indices in bronchiectasis.<br>[250, 255] inflammatory components in bronchiectasis.<br></td>
</tr>
